COVID-19 infection and cardiac angiosarcoma: a dangerous combination-a case report

Area of Science:

• Cardiovascular Pathology
• Oncology
• Infectious Disease Epidemiology

Background:

• The COVID-19 pandemic has severely impacted global healthcare systems, particularly in resource-limited settings.
• Primary heart angiosarcoma, a rare and aggressive malignancy, presents with vague symptoms, increasing the risk of delayed diagnosis.
• Limited healthcare capacity and the overwhelming focus on COVID-19 can exacerbate diagnostic delays for other critical conditions.

Observation:

• A 28-year-old female presented with cough, hemoptysis, and CT findings suggestive of pneumonia.
• Misdiagnosis occurred due to the prevailing COVID-19 pandemic context in Ecuador.
• The patient was ultimately diagnosed with primary heart angiosarcoma but suffered fatal complications.

Findings:

• Primary heart angiosarcoma is frequently diagnosed at advanced stages with metastasis.
• Vague and misleading clinical manifestations contribute to the high rate of missed diagnoses.
• Pandemic conditions can significantly worsen the diagnostic timeline for rare diseases.

Implications:

• Increased clinical awareness of primary heart angiosarcoma is crucial, even during pandemics.
• Differentiating rare conditions from COVID-19 is vital to prevent adverse patient outcomes.
• Prompt diagnosis and management are critical for improving survival rates in cardiac malignancies.